-
公开(公告)号:US20100227870A1
公开(公告)日:2010-09-09
申请号:US12663739
申请日:2008-06-12
IPC分类号: A61K31/4965 , C07D241/04 , A61P25/18
CPC分类号: C07D295/185
摘要: The invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof for treating diseases and conditions mediated by positive allosteric modulation of the G-protein coupled metabotropic subtype 5 receptor (mGluR5), such as neurological and psychiatric disorders, for example schizophrenia. In addition, the invention relates to compositions containing the derivatives and processes for their preparation.
摘要翻译: 本发明提供式(I)化合物或其药学上可接受的盐,用于治疗由G-蛋白偶联的代谢型5型受体(mGluR5)的正性变构调节介导的疾病和病症,例如神经和精神疾病,例如精神分裂症 。 此外,本发明涉及含有衍生物的组合物及其制备方法。
-
2.
公开(公告)号:US08530478B2
公开(公告)日:2013-09-10
申请号:US13054265
申请日:2009-07-15
申请人: Paul John Beswick , Alister Campbell , Andrew Peter Cridland , Robert James Gleave , Jag Paul Heer , Neville Hubert Nicholson , Lee William Page , Sadie Vile
发明人: Paul John Beswick , Alister Campbell , Andrew Peter Cridland , Robert James Gleave , Jag Paul Heer , Neville Hubert Nicholson , Lee William Page , Sadie Vile
IPC分类号: A61K31/496 , C07D401/06
CPC分类号: C07D213/81
摘要: The present invention relates to novel piperazine derivatives (I); to processes for their preparation; to pharmaceutical compositions containing the derivatives; and to the use of the derivatives in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial.
摘要翻译: 本发明涉及新型哌嗪衍生物(I); 进行准备; 含有该衍生物的药物组合物; 以及在治疗中使用衍生物治疗阻断Cav2.2钙通道有益的疾病。
-
公开(公告)号:US08329730B2
公开(公告)日:2012-12-11
申请号:US12989700
申请日:2009-04-29
IPC分类号: C07D413/04 , A61K31/4725
CPC分类号: C07D413/04 , C07D413/14
摘要: The present invention relates to novel oxadiazole derivatives having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders.
摘要翻译: 本发明涉及具有药理活性的新型恶二唑衍生物,其制备方法,含有它们的药物组合物及其在治疗各种病症中的用途。
-
4.
公开(公告)号:US08222245B2
公开(公告)日:2012-07-17
申请号:US12747205
申请日:2008-12-19
申请人: Emmanuel Hubert Demont , Jag Paul Heer , John Skidmore , Ian David Wall , Jason Witherington , Thomas Daniel Heightman , David Nigel Hurst , Christopher Norbert Johnson
发明人: Emmanuel Hubert Demont , Jag Paul Heer , John Skidmore , Ian David Wall , Jason Witherington , Thomas Daniel Heightman , David Nigel Hurst , Christopher Norbert Johnson
IPC分类号: A61P17/00 , A61P37/00 , A61K31/55 , C07D223/16 , C07D267/14 , C07D271/06 , C07D413/04 , C07D413/14
CPC分类号: C07D223/16 , C07D267/14 , C07D271/06 , C07D413/04 , C07D413/14
摘要: The present invention relates to novel oxadiazole derivatives having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders.
摘要翻译: 本发明涉及具有药理活性的新型恶二唑衍生物,其制备方法,含有它们的药物组合物及其在治疗各种病症中的用途。
-
公开(公告)号:US08288388B2
公开(公告)日:2012-10-16
申请号:US12503125
申请日:2009-07-15
申请人: Paul John Beswick , Alister Campbell , Andrew Cridland , Robert James Gleave , Jag Paul Heer , Neville Hubert Nicholson , Lee William Page , Sadie Vile
发明人: Paul John Beswick , Alister Campbell , Andrew Cridland , Robert James Gleave , Jag Paul Heer , Neville Hubert Nicholson , Lee William Page , Sadie Vile
IPC分类号: A61K31/496 , C07D401/06
CPC分类号: C07D213/81
摘要: The present invention relates to novel piperazine derivatives; to processes for their preparation; to pharmaceutical compositions containing the derivatives; and to the use of the derivatives in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial.
摘要翻译: 本发明涉及新的哌嗪衍生物; 进行准备; 含有该衍生物的药物组合物; 以及在治疗中使用衍生物治疗阻断Cav2.2钙通道有益的疾病。
-
公开(公告)号:US08278324B2
公开(公告)日:2012-10-02
申请号:US12747191
申请日:2008-12-19
IPC分类号: C07D413/04 , A61K31/4725
CPC分类号: C07D217/06 , C07D217/16 , C07D217/22 , C07D413/04
摘要: The present invention relates to novel oxadiazole derivatives having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders.
-
公开(公告)号:US20100273827A1
公开(公告)日:2010-10-28
申请号:US12747191
申请日:2008-12-19
申请人: Jag Paul Heer
发明人: Jag Paul Heer
IPC分类号: A61K31/4725 , C07D401/10 , A61P17/02
CPC分类号: C07D217/06 , C07D217/16 , C07D217/22 , C07D413/04
摘要: The present invention relates to novel oxadiazole derivatives having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders.
摘要翻译: 本发明涉及具有药理活性的新型恶二唑衍生物,其制备方法,含有它们的药物组合物及其在治疗各种病症中的用途。
-
公开(公告)号:US20100099690A1
公开(公告)日:2010-04-22
申请号:US12063433
申请日:2006-08-08
IPC分类号: A61K31/522 , C07D473/04 , A61P3/00 , A61P9/00
CPC分类号: C07D473/06 , C07D473/04
摘要: The present invention relates to compounds which are xanthine derivatives, processes for the manufacture of said derivatives, pharmaceutical formulations containing the active compounds and the use of the compounds in therapy, for example, in the treatment of diseases where under-activation of the HM74A receptor contributes to the disease or where activation of the receptor will be beneficial.
摘要翻译: 本发明涉及作为黄嘌呤衍生物的化合物,用于制备所述衍生物的方法,含有活性化合物的药物制剂以及该化合物在治疗中的用途,例如用于治疗HM74A受体活化不足的疾病 有助于疾病或受体激活将是有益的。
-
公开(公告)号:US20120302746A1
公开(公告)日:2012-11-29
申请号:US13568211
申请日:2012-08-07
申请人: Paul John Beswick , Alister Campbell , Andrew Cridland , Robert James Gleave , Jag Paul Heer , Neville Hubert Nicholson , Lee William Page , Sadie Vile
发明人: Paul John Beswick , Alister Campbell , Andrew Cridland , Robert James Gleave , Jag Paul Heer , Neville Hubert Nicholson , Lee William Page , Sadie Vile
IPC分类号: C07D401/06 , C07D401/14 , C07D405/14 , C07D413/14
CPC分类号: C07D213/81
摘要: The present invention relates to novel piperazine derivatives; to processes for their preparation; to pharmaceutical compositions containing the derivatives; and to the use of the derivatives in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial.
摘要翻译: 本发明涉及新的哌嗪衍生物; 进行准备; 含有该衍生物的药物组合物; 以及在治疗中使用衍生物治疗阻断Cav2.2钙通道有益的疾病。
-
10.
公开(公告)号:US08093249B2
公开(公告)日:2012-01-10
申请号:US12503135
申请日:2009-07-15
申请人: Jag Paul Heer , David Norton , Simon E Ward
发明人: Jag Paul Heer , David Norton , Simon E Ward
IPC分类号: A61K31/497 , C07D487/00
CPC分类号: C07D487/04
摘要: The present invention relates to novel piperazine derivatives; to processes for their preparation; to pharmaceutical compositions containing the derivatives; and to the use of the derivatives in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial.
摘要翻译: 本发明涉及新的哌嗪衍生物; 进行准备; 含有该衍生物的药物组合物; 以及在治疗中使用衍生物治疗阻断Cav2.2钙通道有益的疾病。
-
-
-
-
-
-
-
-
-